> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# SterRx Recalls 240 Drug Lots Over Sterility
- URL: https://www.fdaweb.com/sterrx-recalls-240-drug-lots-over-sterility/
- Published: 2021-11-17T12:00:00.000Z
- Updated: 2026-09-14T17:22:37.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5150600

SterRx has recalled 240 lots of various drug products within their expiry period due to equipment and process issues that could lead to a lack of sterility assurance. To date, SterRx has not received reports of any product complaints or adverse events associated with the issue. Affected products are:

- lmg/ml midazolam in 0.9% sodium chloride
- fentanyl in 0.9% sodium chloride
- lmg/ml morphine sulfate in 0.9% sodium chloride
- lmg/ml morphine sulfate in 5% dextrose
- 125mg diltiazem hcl in 0.7% sodium chloride
- 125mg diltiazem hcl in 5% dextrose
- norepinephrine in 0.9% sodium chloride
- norepinephrine in 5% dextrose
- epinephrine in 0.9% sodium chloride
- phenylephrine in 0.9% sodium chloride
- 150meq sodium bicarbonate in 5% dextrose
- 200mg succinylcholine chloride in 0.9% sodium chloride